Is HOWL or HYPD more undervalued in 2026?

CirclFi compares Werewolf Therapeutics, Inc. (HOWL) and Hyperion DeFi, Inc. (HYPD) using 13 institutional-grade valuation models. HOWL has a Quality of Company score of 4.1/10 while HYPD scores 5.1/10.

Which is a better buy — HOWL or HYPD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HOWL and HYPD valuations compare?

HOWL at $0.46 and HYPD at $3.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HOWL vs HYPD Valuation Comparison 2026 — Intrinsic Value Analysis

HOWL

Biotechnology

Werewolf Therapeutics, Inc.

Quality

4.1

out of 10

Value Trap

LOW

Price

$0.46

Last close

Models

7/13

Active

HYPD

Biotechnology

Hyperion DeFi, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$3.44

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	HOWL Fair Value	HOWL Upside	HYPD Fair Value	HYPD Upside
Bayesian DCF	Intrinsic	$0.18	-59.9%	$0.99	-71.2%
Earnings Power Value	Intrinsic	—	—	$1.61	-61.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.05	-93.6%	$0.73	-82.5%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HOWL vs HYPD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HOWL vs HYPD — Which Stock Is More Undervalued?

HYPD scores higher with a 5.1/10 quality rating vs HOWL's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Werewolf Therapeutics, Inc. (HOWL) and Hyperion DeFi, Inc. (HYPD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HOWL currently trades at $0.46 with a QOC of 4.1/10, while HYPD trades at $3.44 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).